96
Participants
Start Date
November 30, 2006
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2010
Sunitinib, Pemetrexed, Cisplatin, Carboplatin
Dose finding study using Sunitinib daily by oral capsule in a continuous regimen or administered for 2 weeks out of every 3 weeks, with pemetrexed every 3 weeks or also with cisplatin 75 mg/m2 or carboplatin AUC=5 mg\*min/mL until progression or unacceptable toxicity.
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, Ottawa
Pfizer Investigational Site, Montreal
Lead Sponsor
Pfizer
INDUSTRY